956010-88-1Relevant articles and documents
SGC STIMULATORS
-
Paragraph 00236, (2018/05/27)
The present disclosure relates to stimulators of soluble guanylate cyclase (sGC), pharmaceutical formulations comprising them and their uses thereof, alone or in combination with one or more additional agents, for treating various diseases, wherein an inc
Use of 3-(trifluoromethyl)-1H-pyrazolo-[3,4-b]pyridine as a versatile building block
Schirok, Hartmut,Griebenow, Nils,Fürstner, Chantal,Dilmac, Alicia M.
, p. 5597 - 5601 (2015/08/03)
A one-pot multigram synthesis of 3-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridine starting from 2-fluoropyridine using directed ortho metallation (DoM) technique is described. The compound contains an anionically activatable trifluoromethyl group and is a versatile building block for the microwave assisted synthesis of 3-substituted 1H-pyrazolo[3,4-b]pyridines.
Identification of acidic heterocycle-substituted 1H-pyrazolo[3,4-b] pyridines as soluble guanylate cyclase stimulators
Griebenow, Nils,Schirok, Hartmut,Mittendorf, Joachim,Straub, Alexander,Follmann, Markus,Stasch, Johannes-Peter,Knorr, Andreas,Schlemmer, Karl-Heinz,Redlich, Gorden
, p. 1197 - 1200 (2013/03/28)
Novel guanylate cyclase stimulators are disclosed. Design, synthesis, SAR, and pharmacological profile of the compounds are discussed.